Prevalence of Acute and Chronic Viral Seropositivity and Characteristics of Disease in Patients with Psoriatic Arthritis Treated with Cyclosporine: a Post Hoc Analysis from a Sex Point of View on the Observational Study of Infectious Events In...

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2016 Jan 6

PMID 26730206

Citations 3

Authors

Delia Colombo

Sergio Chimenti

Paolo Antonio Grossi

Antonio Marchesoni

Federico Bardazzi

Fabio Ayala

Lucia Simoni

Donatella Vassellatti

Gilberto Bellia

Affiliations

Soon will be listed here.

Abstract

Background: Sex medicine studies have shown that there are sex differences with regard to disease characteristics in immune-mediated inflammatory diseases, including psoriasis, in immune response and susceptibility to viral infections. We performed a post hoc analysis of the Observational Study of infectious events in psoriasis complicated by active psoriatic arthritis (SYNERGY) study in patients with psoriatic arthritis (PsA) treated with immunosuppressive regimens including cyclosporine, in order to evaluate potential between-sex differences in severity of disease and prevalence of viral infections.

Methods: SYNERGY was an observational study conducted in 24 Italian dermatology clinics, which included 238 consecutively enrolled patients with PsA, under treatment with immunosuppressant regimens including cyclosporin A. In this post hoc analysis, patients' demographical data and clinical characteristics of psoriasis, severity and activity of PsA, prevalence of seropositivity for at least one viral infection, and treatments administered for PsA and infections were compared between sexes.

Results: A total of 225 patients were evaluated in this post hoc analysis, and 121 (54%) were males. Demographic characteristics and concomitant diseases were comparable between sexes. Statistically significant sex differences were observed at baseline in Psoriasis Area and Severity Index score (higher in males), mean number of painful joints, Bath Ankylosing Spondylitis Disease Activity Index, and the global activity of disease assessed by patients (all higher in females). The percentage of patients with at least one seropositivity detected at baseline, indicative of concomitant or former viral infection, was significantly higher among women than among men. No between-sex differences were detected in other measures, at other time points, and in treatments. Patients developed no hepatitis B virus or hepatitis C virus reactivation during cyclosporine treatment.

Conclusion: Our post hoc sex analysis suggests that women with PsA have a greater articular involvement and a higher activity of disease compared to males. Immunosuppressive treatment with cyclosporine seems not to increase susceptibility to new infections or infectious reactivations, with no sex differences.

Citing Articles

Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials.

Eder L, Tony H, Odhav S, Agirregoikoa E, Korkosz M, Schwartzman S Rheumatol Ther. 2022; 9(3):919-933.

PMID: 35397092 PMC: 9127019. DOI: 10.1007/s40744-022-00445-w.

The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): a post-hoc between-sex analysis.

Colombo D, Zullo A, Simoni L, Zagni E BMC Nephrol. 2019; 20(1):475.

PMID: 31870321 PMC: 6929500. DOI: 10.1186/s12882-019-1656-8.

Gender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis.

Colombo D, Zagni E, Nica M, Rizzoli S, Ori A, Bellia G Drug Des Devel Ther. 2016; 10():2917-2927.

PMID: 27695289 PMC: 5028083. DOI: 10.2147/DDDT.S97088.

References

Zandman-Goddard G, Peeva E, Shoenfeld Y . Gender and autoimmunity. Autoimmun Rev. 2007; 6(6):366-72. DOI: 10.1016/j.autrev.2006.10.001. View

Atteno M, Costa L, Matarese A, Caso F, Del Puente A, Cantarini L . The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol. 2014; 33(4):543-7. PMC: 3962579. DOI: 10.1007/s10067-014-2536-z. View

Finzi A, Colombo D, Caputo A, Andreassi L, Chimenti S, Vena G . Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol. 2007; 21(9):1161-9. DOI: 10.1111/j.1468-3083.2007.02079.x. View

Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U . Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. Expert Opin Biol Ther. 2015; 15(5):641-50. DOI: 10.1517/14712598.2015.1011616. View

Icen M, Crowson C, McEvoy M, Dann F, Gabriel S, Kremers H . Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009; 60(3):394-401. PMC: 3028518. DOI: 10.1016/j.jaad.2008.10.062. View

Mease P . Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology. Curr Rheumatol Rep. 2006; 8(5):348-54. DOI: 10.1007/s11926-006-0064-9. View

Sousa H, Silva J, Azevedo L, Pinto-Correia A, Catarino R, Pinto D . Epstein-Barr virus in healthy individuals from Portugal. Acta Med Port. 2012; 24(5):707-12. View

Hernandez-Bello R, Nava-Castro K, Muniz-Hernandez S, Nava-Luna P, Trejo-Sanchez I, Tiempos-Guzman N . Beyond the reproductive effect of sex steroids: their role during immunity to helminth parasite infections. Mini Rev Med Chem. 2012; 12(11):1071-80. DOI: 10.2174/138955712802762149. View

Roriz-Cruz M, Rosset I, Montero-Odasso M . Lower mortality from H1N1 influenza in older Argentineans: men more affected. J Am Geriatr Soc. 2010; 58(9):1813-5. DOI: 10.1111/j.1532-5415.2010.03045.x. View

10.

Lee W, Reveille J, Davis Jr J, Learch T, Ward M, Weisman M . Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2006; 66(5):633-8. PMC: 1954622. DOI: 10.1136/ard.2006.060293. View

11.

Eder L, Thavaneswaran A, Chandran V, Gladman D . Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis. 2012; 72(4):578-82. DOI: 10.1136/annrheumdis-2012-201357. View

12.

Morisco F, Guarino M, La Bella S, DI Costanzo L, Caporaso N, Ayala F . Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis. BMC Gastroenterol. 2014; 14:214. PMC: 4279461. DOI: 10.1186/s12876-014-0214-x. View

13.

Nadkarni S, McArthur S . Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity. Curr Opin Pharmacol. 2013; 13(4):576-81. DOI: 10.1016/j.coph.2013.05.007. View

14.

Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H . Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis. 2011; 5(3):203-10. DOI: 10.1016/j.crohns.2010.12.012. View

15.

Amigoni S, Morelli P, Chatenoud L, Parazzini F . Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women. Climacteric. 2002; 3(1):25-32. DOI: 10.3109/13697130009167596. View

16.

Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh J . The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study. J Rheumatol. 2011; 39(1):154-6. DOI: 10.3899/jrheum.110845. View

17.

Colombo D, Caputo A, Finzi A, Andreassi L, Chimenti S, Vena G . Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE study. Int J Immunopathol Pharmacol. 2010; 23(1):297-306. DOI: 10.1177/039463201002300128. View

18.

McClelland E, Smith J . Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz). 2011; 59(3):203-13. DOI: 10.1007/s00005-011-0124-3. View

19.

Mease P . Psoriatic arthritis: update on pathophysiology, assessment and management. Ann Rheum Dis. 2011; 70 Suppl 1:i77-84. DOI: 10.1136/ard.2010.140582. View

20.

Klein S, Jedlicka A, Pekosz A . The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010; 10(5):338-49. PMC: 6467501. DOI: 10.1016/S1473-3099(10)70049-9. View